17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
==Hisorty and Symptoms==
==Hisorty and Symptoms==
*17-beta-hydroxysteroid dehydrogenase deficiency-3 is clinically characterized by either [[ambiguous]] [[external]] [[genitalia]] or complete female [[external]] [[genitalia]] at birth.
*17-beta-hydroxysteroid dehydrogenase deficiency-3 is clinically characterized by either [[ambiguous]] [[external]] [[genitalia]] or complete female [[external]] [[genitalia]] at birth; As a consequence of impaired [[male]] [[sexual differentiation]] in 46XY individuals.  
* As a consequence of impaired [[male]] [[sexual differentiation]] in 46XY individuals.  
*Further investigations on ambiguous genitalia will eventually lead to findings of [[intersexuality]].  
*Further investigations on ambiguous genitalia will eventually lead to findings of [[intersexuality]].  
*Severely impaired [[virilization]] (often complete absence of male sexual differentiation) can lead to development of female [[external genitalia]].  
*Severely impaired [[virilization]] (often complete absence of male sexual differentiation) can lead to development of female [[external genitalia]].  

Revision as of 08:03, 10 May 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms

17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

Hisorty and Symptoms

  • 17-beta-hydroxysteroid dehydrogenase deficiency-3 is clinically characterized by either ambiguous external genitalia or complete female external genitalia at birth; As a consequence of impaired male sexual differentiation in 46XY individuals.
  • Further investigations on ambiguous genitalia will eventually lead to findings of intersexuality.
  • Severely impaired virilization (often complete absence of male sexual differentiation) can lead to development of female external genitalia.
  • These females are often discovered when there is absence of menarche (first menstruation) and when they begin to virilize during puberty (slowly become more like a man; deepening of the voice, acne, male musculature etc).
  • At careful examination, testis can often be found in the inguinal canal.[1]

References

  1. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, Andersson S; et al. (1999). "17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations". J Clin Endocrinol Metab. 84 (12): 4713–21. doi:10.1210/jcem.84.12.6174. PMID 10599740.

Template:WH Template:WS